{
    "clinical_study": {
        "@rank": "154696", 
        "acronym": "Immuncell-LC", 
        "arm_group": [
            {
                "arm_group_label": "Non-treatment Groups"
            }, 
            {
                "arm_group_label": "Immuncell-LC Groups"
            }
        ], 
        "brief_summary": {
            "textblock": "To observation that long term follow-up study of 'Immuncell-LC groups' and 'Non-treatment\n      groups' in patient undergo curative resection (PEIT, RFA or Operation) for hepatocellular\n      carcinoma in Korea"
        }, 
        "brief_title": "Long Term Follow-Up Study of Immuncell-LC Group and Non-Treatment Group in Hepatocellular Carcinoma Patients.", 
        "completion_date": {
            "#text": "February 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Hepatocellular Carcinoma", 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma", 
                "Carcinoma, Hepatocellular"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Prior to the test, patient is fully explained about the purpose/ contents   and\n             characteristics of the testing medication, and the patient him(her)self, the guardian\n             or the legal representative signed on written consent.\n\n          -  Patients of participated in the(ClinicalTrials.gov Identifier:NCT00699816)clinical\n             trial.\n\n        Exclusion Criteria:\n\n          -  Patient who is incongruent to this clinical trial by sub-investigator's opinion."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "20 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "This long term follow-UP study is observation about the Immuncell-LC Groups' and\n        'Non-treatment Groups' in patient undergo curative resection (PEIT, RFA or Operation) for\n        Hepatocelluar Carcinoma in Korea."
            }
        }, 
        "enrollment": {
            "#text": "230", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 24, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01890291", 
            "org_study_id": "IIC-I02"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Immuncell-LC, Hepatocellular carcinoma", 
        "lastchanged_date": "April 7, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "zip": "110-744"
                    }, 
                    "name": "Seoul National Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "zip": "135-710"
                    }, 
                    "name": "Samsung Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "zip": "138-736"
                    }, 
                    "name": "Asan Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "zip": "425-707"
                    }, 
                    "name": "Korea University Ansan Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "zip": "152-703"
                    }, 
                    "name": "Korea University Guro Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_groups": "2", 
        "official_title": "Long Term Study of 'Immuncell-LC Groups' and 'Non-treatment Groups' in Patient Undergo Curative Resection (PEIT, Radiofrequency Ablation [RFA] or Operation) for Hepatocellular Carcinoma in Korea", 
        "overall_official": [
            {
                "affiliation": "Seoul National University Hospital", 
                "last_name": "Jung Hwan Yoon, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Samsung Medical Center", 
                "last_name": "Joon Hyeok Lee, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Asan Medical Center", 
                "last_name": "Young-Suk Lim, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Korea University", 
                "last_name": "Tae Gin Song, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Korea University Guro Hospital", 
                "last_name": "Jong Eun Yeon, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": [
                "Korea: Insitutional Review Board", 
                "Korea: Ministry of Food and Drug Safety"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Radiological test should be operated by dynamic CT(using 64 cut), dynamic MRI or by angiography.", 
            "measure": "To evaluate recurrence-free survival", 
            "safety_issue": "No", 
            "time_frame": "up to 3 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01890291"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "To determine the response rate to evaluate overall survival and cause specific survival and changes of Alpha feto protein (AFP) figures from baseline to the last observation date.", 
            "safety_issue": "No", 
            "time_frame": "up to 3 years"
        }, 
        "source": "Green Cross Cell Corporation", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Green Cross Cell Corporation", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "3 Years", 
        "verification_date": "October 2013"
    }
}